Search by Drug Name, NDC or Jcode

    J-Code Lookup

    Last Jcode file upload: 1/24/2024

    How To Use This Tool

    This tool allows you to search for the details of a J-code in several ways, including:

    • Drug Name (currently only searching by the generic drug name is supported)
    • HCPCS Code
    • NDC

    For example, you can look up a J-code by NDC. Simply type the NDC into the search box.

    Most J-code detail pages contain a complete HCPCS/NDC crosswalk.

    ***IMPORTANT: Search results will appear at the bottom of the page***

    What Is This Tool?

    Our J-Code lookup tool allows you to find all of the HCPCS (Healthcare Common Procedure Coding System) J-code (and Q-code) drugs and their respective HCPCS Details. In addition, each detail page contains an HCPCS/NDC crosswalk, a billing calculator, and drug information. 

    One of the more popular features of this tool is that it allows you to look up a Jcode by NDC OR by a drug name.

    What Are J-Codes & Q-Codes?

    'J-codes' are drugs that are typically billed through a 'medical' benefit versus a 'pharmacy' benefit under health plans, and are generally not self-administered (i.e. are administered by a health care professional). They consist of chemotherapy drugs and injectable drugs:

    • J0120-J8999 - Drugs Administered Other than Oral Method
    • J9000-J9999 - Chemotherapy Drugs

    Q-Codes are simply temporary codes that the Centers for Medicare & Medicaid Services (CMS) establish for services and supplies that do not yet have a permanent code.

    J-codes and Q-codes are part of the HCPCS Level II code set used for billing for drugs (primarily injectables), supplies, equipment, nonphysician services, and services not represented by CPT codes (Level I HCPCS).  They are often billed along with a procedure-based CPT code. 

    Additional Information

    This tool is free to use but its contents are not available for download or reproduction.

    JCode Directory

    HCPC Drug name
    Q0517 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 60-days
    Q0518 Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription drug, per 90-days
    Q1004 New technology intraocular lens category 4 as defined in federal register notice
    Q1005 New technology intraocular lens category 5 as defined in federal register notice
    Q2004 Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml
    Q2009 Injection, fosphenytoin, 50 mg phenytoin equivalent
    Q2017 Injection, teniposide, 50 mg
    Q2026 Injection, radiesse, 0.1 ml
    Q2028 Injection, sculptra, 0.5 mg
    Q2034 Influenza virus vaccine, split virus, for intramuscular use (agriflu)
    Q2035 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)
    Q2036 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
    Q2037 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
    Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
    Q2039 Influenza virus vaccine, not otherwise specified
    Q2040 Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
    Q2041 Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q2042 Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q2043 Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
    Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
    Q2050 Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
    Q2052 Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)
    Q2053 Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q2054 Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q2055 Idecabtagene vicleucel, up to 460 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q2056 Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Q3001 Radioelements for brachytherapy, any type, each
    Q3014 Telehealth originating site facility fee
    Q3027 Injection, interferon beta-1a, 1 mcg for intramuscular use
    Q3028 Injection, interferon beta-1a, 1 mcg for subcutaneous use